These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644 [TBL] [Abstract][Full Text] [Related]
4. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit. Sullivan J; Tobias JD Am J Ther; 2006; 13(6):473-7. PubMed ID: 17122526 [TBL] [Abstract][Full Text] [Related]
5. Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions. Jones JM; Richter LM; Alonto A; Leedahl DD Am J Health Syst Pharm; 2015 Feb; 72(3):198-202. PubMed ID: 25596602 [TBL] [Abstract][Full Text] [Related]
6. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141 [TBL] [Abstract][Full Text] [Related]
7. Linezolid for the treatment of complicated skin and skin structure infections in children. Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143 [TBL] [Abstract][Full Text] [Related]
8. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142 [TBL] [Abstract][Full Text] [Related]
10. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Sharpe JN; Shively EH; Polk HC Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Bounthavong M; Hsu DI Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574 [TBL] [Abstract][Full Text] [Related]
12. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
13. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections]. Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350 [TBL] [Abstract][Full Text] [Related]
17. Role of linezolid in the treatment of complicated skin and soft tissue infections. Peppard WJ; Weigelt JA Expert Rev Anti Infect Ther; 2006 Jun; 4(3):357-66. PubMed ID: 16771613 [TBL] [Abstract][Full Text] [Related]
18. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of SSTI and role of tigecycline]. Concia E Infez Med; 2009 Sep; 17 Suppl 4():64-76. PubMed ID: 20428022 [TBL] [Abstract][Full Text] [Related]
20. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. McKinnon PS; Sorensen SV; Liu LZ; Itani KM Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]